Complex Antibody Expression - Challenge Accepted

As biologics grow more complex—shifting from classical antibodies to bi- and multispecific formats—traditional cell line development platforms are being pushed to their limits. This webinar explores how Sartorius’ CHO Cell Line Development Service meets these challenges head-on, delivering stable, high-yielding cell lines tailored to advanced therapeutic formats. By integrating automation, data modeling, and a robust clone selection strategy, Sartorius enables efficient development of CHO production cell lines with consistent product quality. Explore real-world case studies that highlight customized approaches for complex biologics to demonstrate how these solutions not only met but exceeded customer expectations.

Whether you're navigating the demands of next-gen biologics or refining your current development workflows, learn more about practical insights and proven strategies.